rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jacob Vincent Micallef

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, VolitionRX.

In numbers

Trades disclosed
91
Buys
9
Sells
0
Bought
$241K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
13 Dec 2012
Last trade
17 Mar 2026
Last filed
19 Mar 2026

Companies traded

Where they are an officer
VNRX VolitionRXOfficer · Diagnostics & Labs · last 17 Mar 20269 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Mar 2026filed 19 Mar 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$1,0095,310 at $0.19filing
17 Mar 2026filed 19 Mar 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$1,0095,310 at $0.19filing
26 Feb 2026filed 27 Feb 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—149,000 at $0.00filing
26 Feb 2026filed 27 Feb 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—149,000 at $0.00filing
22 Jan 2026filed 23 Jan 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—35,400 at $0.00filing
22 Jan 2026filed 23 Jan 2026VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—35,400 at $0.00filing
4 Oct 2025filed 7 Oct 2025VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$3,8035,850 at $0.65filing
28 Sep 2025filed 30 Sep 2025VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$3,3965,568 at $0.61filing
1 Jun 2025filed 3 Jun 2025VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$11K21,526 at $0.50filing
19 May 2025filed 19 May 2025VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Bought$22K50,000 at $0.43filing
1 May 2025filed 5 May 2025VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$8,97618,319 at $0.49filing
29 Jan 2025filed 31 Jan 2025VNRX VolitionRXoption or derivative · Diagnostics & LabsSEC FORM 4 Code D—50,000filing
29 Jan 2025filed 31 Jan 2025VNRX VolitionRXoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—50,000filing
9 Dec 2024filed 10 Dec 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Bought$25K43,691 at $0.57filing
4 Oct 2024filed 8 Oct 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$4,5765,200 at $0.88filing
28 Sep 2024filed 1 Oct 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code F$2,8714,950 at $0.58filing
1 Sep 2024filed 4 Sep 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—47,837 at $0.00filing
15 Aug 2024filed 16 Aug 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—13,750 at $0.00filing
1 Jun 2024filed 4 Jun 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—40,709 at $0.00filing
24 Jan 2024filed 26 Jan 2024VNRX VolitionRXDiagnostics & LabsSEC FORM 4 Code A—23,375 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care9

Buys in green, sells in red, by the company’s sector.

Related people

Ann-Louise BatchelorGroup Chief Marketing Officer · Group Chief Marketing Officer at Volitionrx, filing Form 4 there in the last year
Gael ForterreChief Commercial Officer · Chief Commercial Officer at Volitionrx, filing Form 4 there in the last year
Gaetan MichelChief Operating Officer · Chief Operating Officer at Volitionrx, filing Form 4 there in the last year
Rodney Gerard RootsaertSecretary · Secretary at Volitionrx, filing Form 4 there in the last year
Nicholas PlummerGC - Volition Diagnostics · GC - Volition Diagnostics at Volitionrx, filing Form 4 there in the last year